Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thrombin | 8 | 2016 | 613 | 2.150 |
Why?
|
| Glycomics | 4 | 2020 | 123 | 1.230 |
Why?
|
| Lignin | 3 | 2016 | 17 | 1.220 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 3 | 2016 | 140 | 1.190 |
Why?
|
| Microarray Analysis | 4 | 2020 | 780 | 0.850 |
Why?
|
| Polysaccharides | 9 | 2022 | 993 | 0.820 |
Why?
|
| Glycopeptides | 1 | 2020 | 208 | 0.730 |
Why?
|
| Glycoproteins | 3 | 2021 | 2313 | 0.640 |
Why?
|
| Antithrombins | 3 | 2015 | 297 | 0.620 |
Why?
|
| Anticoagulants | 4 | 2016 | 4368 | 0.590 |
Why?
|
| Software | 2 | 2020 | 4350 | 0.560 |
Why?
|
| Tyrosine | 1 | 2020 | 1508 | 0.550 |
Why?
|
| Platelet Aggregation | 2 | 2016 | 808 | 0.510 |
Why?
|
| Data Mining | 1 | 2019 | 543 | 0.510 |
Why?
|
| Blood Coagulation | 4 | 2016 | 1110 | 0.450 |
Why?
|
| Drug Design | 4 | 2013 | 1106 | 0.440 |
Why?
|
| Glycosylation | 4 | 2022 | 1138 | 0.390 |
Why?
|
| Sulfates | 3 | 2016 | 377 | 0.370 |
Why?
|
| Lectins, C-Type | 2 | 2022 | 610 | 0.340 |
Why?
|
| Allosteric Regulation | 6 | 2016 | 423 | 0.340 |
Why?
|
| Thromboembolism | 1 | 2013 | 985 | 0.310 |
Why?
|
| Factor XIa | 2 | 2014 | 8 | 0.260 |
Why?
|
| Heparin | 3 | 2016 | 1636 | 0.250 |
Why?
|
| Benzofurans | 3 | 2014 | 150 | 0.250 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2020 | 1637 | 0.240 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2016 | 3004 | 0.230 |
Why?
|
| Antibodies | 2 | 2020 | 2445 | 0.220 |
Why?
|
| Serine Proteinase Inhibitors | 2 | 2013 | 187 | 0.210 |
Why?
|
| Mannose-Binding Lectins | 1 | 2021 | 105 | 0.210 |
Why?
|
| Allosteric Site | 3 | 2016 | 110 | 0.200 |
Why?
|
| Galectin 3 | 1 | 2022 | 217 | 0.200 |
Why?
|
| Fluorescence Polarization | 1 | 2020 | 134 | 0.200 |
Why?
|
| Protease Inhibitors | 2 | 2016 | 829 | 0.190 |
Why?
|
| Hydrolysis | 3 | 2016 | 731 | 0.190 |
Why?
|
| Protein Binding | 5 | 2016 | 9660 | 0.190 |
Why?
|
| Glycosyltransferases | 1 | 2020 | 110 | 0.190 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2019 | 84 | 0.180 |
Why?
|
| Oligosaccharides | 1 | 2021 | 402 | 0.180 |
Why?
|
| Serum | 1 | 2020 | 218 | 0.180 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2019 | 178 | 0.180 |
Why?
|
| Propylamines | 1 | 2019 | 165 | 0.180 |
Why?
|
| Peptide Library | 1 | 2020 | 352 | 0.180 |
Why?
|
| Carbohydrates | 1 | 2020 | 358 | 0.170 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2020 | 516 | 0.170 |
Why?
|
| Chromatography, Reverse-Phase | 1 | 2016 | 20 | 0.160 |
Why?
|
| Fluorescence | 1 | 2019 | 770 | 0.160 |
Why?
|
| Thrombelastography | 2 | 2016 | 158 | 0.160 |
Why?
|
| Molecular Mimicry | 2 | 2014 | 205 | 0.150 |
Why?
|
| Binding Sites | 5 | 2020 | 6289 | 0.150 |
Why?
|
| Bleeding Time | 1 | 2016 | 90 | 0.150 |
Why?
|
| Coumarins | 1 | 2016 | 123 | 0.140 |
Why?
|
| Glycosaminoglycans | 2 | 2016 | 603 | 0.140 |
Why?
|
| Catalytic Domain | 2 | 2016 | 724 | 0.140 |
Why?
|
| Kinetics | 5 | 2015 | 6802 | 0.140 |
Why?
|
| Thermodynamics | 2 | 2014 | 618 | 0.140 |
Why?
|
| Glucuronic Acid | 1 | 2015 | 147 | 0.140 |
Why?
|
| Propionates | 1 | 2015 | 181 | 0.140 |
Why?
|
| Blood Coagulation Tests | 1 | 2016 | 268 | 0.130 |
Why?
|
| Antigens | 1 | 2020 | 1511 | 0.130 |
Why?
|
| Workflow | 1 | 2019 | 811 | 0.130 |
Why?
|
| Static Electricity | 1 | 2014 | 271 | 0.130 |
Why?
|
| Prodrugs | 1 | 2015 | 270 | 0.130 |
Why?
|
| Protein Conformation | 4 | 2016 | 4069 | 0.130 |
Why?
|
| Enoxaparin | 1 | 2016 | 361 | 0.120 |
Why?
|
| Platelet-Rich Plasma | 1 | 2016 | 173 | 0.120 |
Why?
|
| Sulfuric Acid Esters | 1 | 2013 | 28 | 0.120 |
Why?
|
| Hemostasis | 1 | 2016 | 452 | 0.120 |
Why?
|
| Documentation | 1 | 2019 | 869 | 0.120 |
Why?
|
| Antirheumatic Agents | 1 | 2023 | 1366 | 0.120 |
Why?
|
| Structure-Activity Relationship | 3 | 2013 | 3247 | 0.120 |
Why?
|
| Binding, Competitive | 1 | 2014 | 1209 | 0.110 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2013 | 291 | 0.110 |
Why?
|
| Platelet Activation | 1 | 2016 | 657 | 0.110 |
Why?
|
| Sodium Chloride | 1 | 2014 | 637 | 0.110 |
Why?
|
| Tetrahydroisoquinolines | 1 | 2012 | 100 | 0.110 |
Why?
|
| Patents as Topic | 1 | 2013 | 144 | 0.110 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 2043 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 2916 | 0.100 |
Why?
|
| Legislation, Drug | 1 | 2013 | 227 | 0.100 |
Why?
|
| Vasodilator Agents | 1 | 2015 | 1008 | 0.100 |
Why?
|
| Sucrose | 1 | 2011 | 186 | 0.100 |
Why?
|
| Aniline Compounds | 1 | 2015 | 961 | 0.100 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2016 | 1116 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2014 | 1788 | 0.100 |
Why?
|
| Glucosides | 1 | 2013 | 373 | 0.090 |
Why?
|
| Hemoglobins | 1 | 2015 | 1501 | 0.090 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 737 | 0.090 |
Why?
|
| Animals | 9 | 2022 | 170733 | 0.090 |
Why?
|
| Protein Kinase C | 1 | 2014 | 1278 | 0.090 |
Why?
|
| Molecular Structure | 1 | 2013 | 1983 | 0.090 |
Why?
|
| Internet | 1 | 2020 | 3078 | 0.080 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2023 | 3677 | 0.080 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 2189 | 0.080 |
Why?
|
| Nitric Oxide | 1 | 2015 | 2121 | 0.080 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 2252 | 0.070 |
Why?
|
| Fibrinolytic Agents | 1 | 2016 | 2139 | 0.070 |
Why?
|
| Heparitin Sulfate | 2 | 2016 | 218 | 0.070 |
Why?
|
| Hemorrhage | 1 | 2016 | 3273 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 6858 | 0.060 |
Why?
|
| Risk | 1 | 2016 | 9772 | 0.060 |
Why?
|
| Mice | 3 | 2022 | 80997 | 0.060 |
Why?
|
| 4-1BB Ligand | 1 | 2022 | 28 | 0.060 |
Why?
|
| Factor Xa | 2 | 2015 | 162 | 0.060 |
Why?
|
| Mannose | 1 | 2022 | 124 | 0.060 |
Why?
|
| Thrombosis | 1 | 2016 | 2852 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2016 | 6075 | 0.060 |
Why?
|
| Carbohydrate Sequence | 2 | 2013 | 417 | 0.050 |
Why?
|
| Humans | 18 | 2023 | 715118 | 0.050 |
Why?
|
| Models, Molecular | 3 | 2021 | 5535 | 0.050 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2012 | 458 | 0.050 |
Why?
|
| Galectins | 1 | 2023 | 249 | 0.050 |
Why?
|
| Carbohydrate Conformation | 1 | 2019 | 205 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2022 | 614 | 0.050 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2019 | 154 | 0.040 |
Why?
|
| ABO Blood-Group System | 1 | 2020 | 363 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 2019 | 1432 | 0.040 |
Why?
|
| Chickens | 1 | 2019 | 879 | 0.040 |
Why?
|
| Heparin Lyase | 1 | 2016 | 37 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 22941 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 12566 | 0.040 |
Why?
|
| Immunity, Humoral | 1 | 2020 | 583 | 0.040 |
Why?
|
| Influenza A virus | 1 | 2019 | 453 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 1734 | 0.040 |
Why?
|
| Biotransformation | 1 | 2015 | 164 | 0.040 |
Why?
|
| Receptors, Virus | 1 | 2019 | 658 | 0.040 |
Why?
|
| Polymerization | 1 | 2016 | 173 | 0.040 |
Why?
|
| Heparin Cofactor II | 1 | 2015 | 3 | 0.040 |
Why?
|
| Cattle | 2 | 2012 | 3998 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2020 | 1531 | 0.030 |
Why?
|
| Antigens, Viral | 1 | 2019 | 1164 | 0.030 |
Why?
|
| Ligands | 1 | 2021 | 3333 | 0.030 |
Why?
|
| Blood Coagulation Factors | 1 | 2016 | 370 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 2497 | 0.030 |
Why?
|
| Influenza Vaccines | 1 | 2019 | 689 | 0.030 |
Why?
|
| Epitopes | 1 | 2019 | 2654 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2023 | 3215 | 0.030 |
Why?
|
| Digestion | 1 | 2012 | 61 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2022 | 4321 | 0.030 |
Why?
|
| Carboxylic Acids | 1 | 2012 | 106 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2023 | 4284 | 0.030 |
Why?
|
| Dimerization | 1 | 2013 | 908 | 0.030 |
Why?
|
| Ultracentrifugation | 1 | 2011 | 200 | 0.030 |
Why?
|
| Prothrombin Time | 1 | 2011 | 123 | 0.030 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2013 | 293 | 0.030 |
Why?
|
| Partial Thromboplastin Time | 1 | 2011 | 211 | 0.030 |
Why?
|
| Erythrocytes | 1 | 2019 | 2421 | 0.020 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2011 | 328 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2022 | 3426 | 0.020 |
Why?
|
| Mutation | 1 | 2014 | 29441 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2011 | 722 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2013 | 1900 | 0.020 |
Why?
|
| Influenza, Human | 1 | 2019 | 1378 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2013 | 962 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 4482 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 18734 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2019 | 8738 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2011 | 2020 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2013 | 3879 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2014 | 1067 | 0.020 |
Why?
|
| Proteins | 1 | 2020 | 6163 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2020 | 7836 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2013 | 3705 | 0.010 |
Why?
|
| Algorithms | 1 | 2015 | 13669 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 56155 | 0.010 |
Why?
|
| Male | 2 | 2020 | 351080 | 0.010 |
Why?
|
| Female | 2 | 2020 | 377328 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 212128 | 0.000 |
Why?
|
| Middle Aged | 1 | 2020 | 214868 | 0.000 |
Why?
|
Concepts
(168)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_